Ironwood Pharmaceuticals (IRWD) EPS (Weighted Average and Diluted): 2010-2025
Historic EPS (Weighted Average and Diluted) for Ironwood Pharmaceuticals (IRWD) over the last 10 years, with Sep 2025 value amounting to $0.23.
- Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) rose 1050.00% to $0.23 in Q3 2025 from the same period last year, while for Sep 2025 it was $0.15, marking a year-over-year increase of 600.00%. This contributed to the annual value of $0.01 for FY2024, which is 100.16% up from last year.
- Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) amounted to $0.23 in Q3 2025, which was up 64.29% from $0.14 recorded in Q2 2025.
- Over the past 5 years, Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) peaked at $2.39 during Q2 2021, and registered a low of -$6.84 during Q2 2023.
- Its 3-year average for EPS (Weighted Average and Diluted) is -$0.58, with a median of $0.01 in 2024.
- In the last 5 years, Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) crashed by 3,357.14% in 2023 and then spiked by 1,500.00% in 2025.
- Over the past 5 years, Ironwood Pharmaceuticals' EPS (Weighted Average and Diluted) (Quarterly) stood at $0.25 in 2021, then increased by 8.00% to $0.27 in 2022, then crashed by 103.70% to -$0.01 in 2023, then surged by 200.00% to $0.01 in 2024, then surged by 1,050.00% to $0.23 in 2025.
- Its last three reported values are $0.23 in Q3 2025, $0.14 for Q2 2025, and -$0.23 during Q1 2025.